ETFChannel.com
iShares Genomics Immunology and Healthcare ETF

IDNA — Key Stats (updated 8 HRs, 53 MINs ago)
Fund Name:
iShares Genomics Immunology and Healthcare ETF
Issuer:
iShares
Total Net Assets:
$147,071,306
Inception:
NA
Related Index:
NYSE FactSet Global Genomics and Immuno Biopharma Index
ETF Category: 
Health
Expense Ratio: 
0.47% 
Net Asset Value: 
$23.92  
Recent NAV Premium: 
0.00% 
NAV Symbol: 
IDNA.NV  
Number of Holdings: 
52  
Annualized Yield: 
0.61%  
Annualized Distribution: 
0.146  
IDNA Dividend History » 
IDNA — Top Stock Holdings
Stock Weight Amount
Blueprint Medicines 5.56% $8,176,220
Beigene Ltd 5.51% $8
Sanofi SA 5.49% $8
Exelixis 5.24% $7,702,006
Takeda Pharmaceutical Ltd 5.08% $7
List of all 64 stocks held by IDNA »
IDNA — Price Chart
IDNA — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree IDNA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Avg. Broker Rec.

Buy (3.31 out of 4)
77th percentile
(ranked higher than approx. 77% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
IDNA — Performance
More iShares ETFs
ETF Assets
IVV   $313,115,193,630
IEFA   $96,378,443,117
AGG   $90,174,684,986
IEMG   $68,678,190,652
IWF   $66,767,691,177
List of all 312 others »
IDNA — Short Interest
Shares Short 1,999
Chg. from Last Month +162
Shares Outstanding 6,150,000
% of Shares Short 0.03%
Days to Cover 0.1
Based on third party short interest data.

IDNA | iShares Genomics Immunology and Healthcare ETF | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.